GxPinnacle Logo
Skip to content

What Do Inspectors Check for Training Compliance Monitoring and Metrics in Pharmacovigilance?

Pharmacovigilance systems must monitor training compliance using defined metrics. Regulators expect tracking of completion rates, overdue training, compliance reporting, and escalation where training requirements are not met.

For: Founders, CEOs & MDs·PV Leads·QA/Compliance·Scientists tasked with documentation

Alignment: Global pharmacovigilance principles (ICH-aligned) and inspection practices

Most useful when: Preparing for inspection, setting up a process, or closing a documentation gap

Key points

  • Pharmacovigilance systems must monitor training compliance using defined metrics.
  • Training completion must be tracked at individual, role, and organisational level.
  • Metrics must include completion rates, overdue training, and compliance percentages.
  • Training compliance must be reviewed regularly and reported to management.
  • Non-compliance must be identified, followed up, and escalated where necessary.
  • Inspection-ready evidence must demonstrate active monitoring and control of training compliance.

What inspectors expect

Each point below should be supported by controlled documents and traceable records.

  • Training compliance must be actively monitored.
  • Training completion must be measurable.
  • Overdue training must be identified and managed.
  • Training metrics must be reviewed regularly.
  • Non-compliance must be escalated and addressed.

Summary

Inspectors assess whether pharmacovigilance systems actively monitor training compliance. They review training metrics, completion rates, overdue training, and evidence that non-compliance is identified, managed, and escalated appropriately.

Common questions

These are the questions this page is designed to answer directly.

  • How is training compliance monitored in pharmacovigilance?
  • What metrics are used for PV training compliance?
  • What do inspectors check for training compliance?
  • How do you track overdue training in PV systems?
  • What is a training compliance tracker?
  • How do regulators assess training compliance monitoring?
  • How do you measure training completion in pharmacovigilance?
  • What happens if training is overdue in PV?
  • How do you report training compliance?
  • How do you ensure training compliance across teams?

Evidence objects inspectors expect

Training Compliance Tracker

  • Team or department-level compliance reports
  • Percentage completion of required training
  • Overdue training counts
  • Regular updates showing training status

Training Metrics and Reporting

  • Monthly or quarterly training compliance reports
  • Compliance percentage calculations
  • Trend analysis of training completion over time
  • Management-level reporting of training status

Overdue Training Monitoring

  • Identification of overdue training by individual
  • Tracking of delayed completion
  • Follow-up actions for non-compliance
  • Escalation of persistent overdue training

Training Compliance Governance

  • Review of training metrics by PV training lead or QA
  • Management review of compliance reports
  • Defined escalation pathways for non-compliance
  • Documentation of actions taken to address gaps

Corrective Actions for Non-Compliance

  • Follow-up by line managers
  • Retraining requirements for missed training
  • Escalation to QA or senior management
  • Documentation of compliance recovery actions

Regulatory Basis (Primary Sources)

  • GVP Module I – requirement for trained personnel and oversight of competence
  • GVP Module II – requirement for documentation supporting PV system operation
  • ICH E2D – expectation for trained personnel managing safety data
  • MHRA GPvP guidance – expectations for monitoring training compliance
  • FDA pharmacovigilance guidance – requirement for ensuring trained and competent staff

Typical Inspection Questions (What Inspectors Ask)

  • How do you monitor training compliance?
  • Show me your training compliance metrics.
  • How do you identify overdue training?
  • What happens when training is not completed on time?
  • How is training compliance reported to management?

Failure patterns

Training compliance is not tracked or measured.

Overdue training is not identified or followed up.

Training metrics are not reviewed by management.

Non-compliance is not escalated or addressed.

Training data is incomplete or inconsistent.

What good looks like

  • Clear tracking of training completion and compliance.
  • Regular reporting of training metrics.
  • Identification and management of overdue training.
  • Active governance and review of training compliance.
  • Effective escalation and resolution of non-compliance.

Operationalisation

  • Implement a training compliance tracker or system.
  • Define metrics such as completion rates and overdue training.
  • Review training compliance regularly.
  • Follow up with individuals who have overdue training.
  • Escalate persistent non-compliance.
  • Report training compliance to management.

Need regulatory documentation today?

Save time and reduce inspection risk with structured, pre-built process-ready documentation.
Created by industry professionals, adaptable to your organisation.

Related pre-built documentation inside the app

Get AccessLog In

FAQ

How is training compliance monitored in pharmacovigilance?

Training compliance is monitored using trackers or systems that record completion rates, overdue training, and compliance metrics across individuals and teams.

What metrics are used to measure training compliance?

Common metrics include percentage of completed training, number of overdue courses, compliance rate by department, and trends over time.

What happens if training is overdue in pharmacovigilance?

Overdue training must be followed up by line managers and escalated if not completed, with corrective actions taken to restore compliance.

Do inspectors review training compliance metrics?

Yes. Inspectors review training metrics and compliance reports to confirm that training is actively monitored and controlled.

How often should training compliance be reviewed?

Training compliance is typically reviewed monthly or quarterly, depending on organisational requirements and risk.

Why is training compliance monitoring important?

Monitoring ensures that all personnel remain trained and compliant, reducing regulatory risk and maintaining system integrity.

Sources

Primary guidance used to inform this map. This page is a structured interpretation layer; always validate against the original source documents.

European Medicines Agency (EMA)

  • Guideline on good pharmacovigilance practices (GVP) – Module I
    View source
  • Guideline on good pharmacovigilance practices (GVP) – Module II
    View source

FDA

ICH

MHRA